Futura Medical (LON:FUM) Trading Down 8.7% – Here’s What Happened

Futura Medical plc (LON:FUM) shares fell 8.7% on Monday . The stock traded as low as GBX 1.03 and last traded at GBX 1.08. 14,622,258 shares traded hands during trading, an increase of 517% from the average session volume of 2,369,161 shares. The stock had previously closed at GBX 1.18.

Futura Medical Stock Up 3.2%

The stock has a 50 day simple moving average of GBX 1.75 and a 200 day simple moving average of GBX 6.15. The company has a market capitalization of £3.76 million, a price-to-earnings ratio of -0.54 and a beta of 1.25.

Futura Medical (LON:FUM) last announced its quarterly earnings results on Tuesday, September 30th. The company reported GBX (2.17) earnings per share for the quarter. Futura Medical had a negative return on equity of 56.44% and a negative net margin of 44.64%. As a group, analysts forecast that Futura Medical plc will post 2.8486672 EPS for the current year.

Insiders Place Their Bets

In other Futura Medical news, insider Harmesh Suniara sold 4,441,678 shares of the firm’s stock in a transaction on Thursday, November 13th. The stock was sold at an average price of GBX 2, for a total value of £88,833.56. 25.86% of the stock is owned by corporate insiders.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.